Cargando…
HMGB1 siRNA can reduce damage to retinal cells induced by high glucose in vitro and in vivo
BACKGROUND: Diabetic retinopathy (DR), one of the most common complications of late-phase diabetes, is associated with many risk factors, among which continuous low-grade inflammation is one of the principal ones. As such, lowering inflammation levels and maintain the viability of human retinal endo...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5359008/ https://www.ncbi.nlm.nih.gov/pubmed/28352154 http://dx.doi.org/10.2147/DDDT.S129913 |